Evidence map›Paper›PMID 23819499›Full record

ArticleACS chemical biology2013

Inhibitors of difficult protein-protein interactions identified by high-throughput screening of multiprotein complexes.

Laura C Cesa, Srikanth Patury, Tomoko Komiyama, Atta Ahmad, Erik R P Zuiderweg, Jason E Gestwicki

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Dynamical Structures of Hsp70 and Hsp70-Hsp40 Complexes.Structure (London, England : 1993) · 2016
    Review
  18. Motif mediated protein-protein interactions as drug targets.Cell communication and signaling : CCS · 2016
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Laura C Cesa *Departments of Pathology and Biological Chemistry and the Life Sciences Institute University of Michigan, Ann Arbor, MI 48109-2216.
Srikanth Patury *Departments of Pathology and Biological Chemistry and the Life Sciences Institute University of Michigan, Ann Arbor, MI 48109-2216.
Tomoko KomiyamaDepartments of Pathology and Biological Chemistry and the Life Sciences Institute University of Michigan, Ann Arbor, MI 48109-2216.
Atta AhmadDepartments of Pathology and Biological Chemistry and the Life Sciences Institute University of Michigan, Ann Arbor, MI 48109-2216.
Erik R P ZuiderwegDepartments of Pathology and Biological Chemistry and the Life Sciences Institute University of Michigan, Ann Arbor, MI 48109-2216.
Jason E GestwickiDepartments of Pathology and Biological Chemistry and the Life Sciences Institute University of Michigan, Ann Arbor, MI 48109-2216.
University of Michigan–Ann Arbor · US

Funding

Molecular Chaperones and Small MoleculesR01NS059690 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jason E Gestwicki · 2008 to 2026
$7.9M
NINDS NIH HHS NS059690NINDS NIH HHS R01 NS059690
6 · The paper itself

Abstract

Protein-protein interactions (PPIs) are important in all aspects of cellular function, and there is interest in finding inhibitors of these contacts. However, PPIs with weak affinities and/or large interfaces have traditionally been more resistant to the discovery of inhibitors, partly because it is more challenging to develop high-throughput screening (HTS) methods that permit direct measurements of these physical interactions. Here, we explored whether the functional consequences of a weak PPI might be used as a surrogate for binding. As a model, we used the bacterial ATPase DnaK and its partners DnaJ and GrpE. Both DnaJ and GrpE bind DnaK and catalytically accelerate its ATP cycling, so we used stimulated nucleotide turnover to indirectly report on these PPIs. In pilot screens, we identified compounds that block activation of DnaK by either DnaJ or GrpE. Interestingly, at least one of these molecules blocked binding of DnaK to DnaJ, while another compound disrupted allostery between DnaK and GrpE without altering the physical interaction. These findings suggest that the activity of a reconstituted multiprotein complex might be used in some cases to identify allosteric inhibitors of challenging PPIs.

Indexed as

Drug DiscoveryDrug Evaluation, PreclinicalEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsHeat-Shock ProteinsHigh-Throughput Screening AssaysHSP40 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsHumansModels, MolecularProtein Interaction MapsDnaJ protein, E colidnaK protein, E coliEscherichia coli ProteinsGrpE protein, E coliHeat-Shock ProteinsHSP40 Heat-Shock ProteinsHSP70 Heat-Shock Proteins

Identifiers

PMID23819499
PMCPMC3783524
OpenAlexW2164721093

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.